A glitch in Medicare's revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts.
Nov 21, 2019
0
3
The American College of Physicians (ACP) today released new policy papers calling for changes that would mitigate rising prescription drug costs. Policy Recommendations for Public Health Plans to Stem the Escalating Costs ...
Nov 12, 2019
0
1
New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016. The study showed post-market ...
Nov 10, 2019
0
1
Biologics used to treat patients can be incredibly expensive, so there was significant hope that biosimilar drugs—which are highly similar to an existing biologic drug on the market—could serve as a less-costly substitute. ...
Nov 4, 2019
0
7
Many current inhalers for conditions such as asthma contain propellants that are potent greenhouse gases. A study from researchers at the University of Cambridge has found that switching to alternative, greener inhalers would ...
Oct 29, 2019
0
2
Syringe exchange programs established in Philadelphia and Baltimore prevented a total of 12,483 new cases of HIV over a ten-year period, according to a study published today. The averted HIV infections also saved both cities ...
Oct 29, 2019
0
0
An essential medicines list in Canada should be evidence-based and independent of conflicting interests, found a study of decision-makers and policy-makers that is published in CMAJ (Canadian Medical Association Journal).
Oct 7, 2019
0
1
Many new anti-cancer medicines add little value for patients compared to standard treatment and are rarely worth the extra cost, according to results of two studies investigating links between clinical benefit and pricing ...
Sep 27, 2019
0
1
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they ...
Sep 23, 2019
0
5
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network ...
Sep 18, 2019
0
0
